Question-and-Answer Session
Operator
Thank you. (Operator Instructions). We'll go to Greg Brash with Sidoti & Company.
Greg Brash
Hi, Larry. Hi, Hank and Nino.
Larry Saper
Hi.
Greg Brash
A very strong growth in Cardiac Assist here, would you be willing to break down the growth rate in international versus US and also quantify the size of its stocking order?
Hank Scaramelli
I'll answer that Greg. The stock-in-order is less than 2% of the total corporation sales for the quarter. And the sales break down for Cardiac for the second quarter, were basically flat in the US, 32% up over last year in the international market.
Greg Brash
Okay. So the stock you know, 2% of the total??
Hank Scaramelli
Less than 2%.
Greg Brash
So around 2 million?
Hank Scaramelli
No less than 2%.
Greg Brash
Okay.
Hank Scaramelli
Less than 2 million.
Greg Brash
Less than 2 million. Okay, and I was just curious have you been able to take advantage at all of one of your main competitor in that space being acquired, maybe some distraction there. And I know a new competitor has entered the space have seen any more of them?
Hank Scaramelli
You are talking about (Kelly Flex) and Arrow?
Greg Brash
Yes.
Hank Scaramelli
Okay. I could answer that but I think Nino might be the more appropriate person to answer it regarding what they're currently doing with their pumps and their transit contracts and the low volume on balloons and what they're doing in the marketplace.
Greg Brash
Okay.
Hank Scaramelli
In terms of pulling out equipment.
Dr. Nino Laudani
Well as I think we don't want to comment on what lets say our competitor is doing. What we have seen. Of course a change in the strategy and I don't think we can say what this exactly is. But we have seen some positive effect in ourselves but again it probably is too early to make the decisive conclusion on that.
Greg Brash
Okay. Switching gears to the patient monitoring and you talked about some deferred shipments to the tightening credit markets. Just curious if you would be willing to quantify what effect that had in this quarter and that happened across the board or is that you are mostly seeing that from the smaller hospitals?
Hank Scaramelli
It is mainly in the US and as you know most of our cold points are the 100 to 200 bed hospitals or the surgery centers. And again, I think you've got to look at it from this standpoint. Orders are up 10% which was strong. But we lost a big order at the end of the quarter that we are going to book in the third quarter for almost $1.5 million.
- To read the full transcript on Seeking Alpha, click here »
